[Rheumatoid arthritis: early aggressive therapy including biologicals -- pro].
Rubbert-Roth
A
A
Medizinische Klinik I der Universität zu Köln. andrea.rubbert@uk-koeln.de
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000191:economics; D018501:Antirheumatic Agents / Q000191:economics / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001688:Biological Products / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D013997:Time Factors; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D001688:Biological Products; D014409:Tumor Necrosis Factor-alpha